Simultaneous delivery of therapeutic antagomirs with paclitaxel for the management of metastatic tumors by a pH-responsive anti-microbial peptide-mediated liposomal delivery system

Huntzinger, 2011, Gene silencing by microRNAs: contributions of translational repression and mRNA decay, Nature, 12, 99 Croce, 2009, Causes and consequences of microRNA dysregulation in cancer, Nat. Rev. Genet., 10, 704, 10.1038/nrg2634 Broderick, 2011, MicroRNA therapeutics, Gene Ther., 18, 1104, 10.1038/gt.2011.50 Garzon, 2010, Targeting microRNAs in cancer: rationale, strategies and challenges, Nat. Rev. Drug Discov., 9, 775, 10.1038/nrd3179 Hurst, 2009, Metastamir: the field of metastasis-regulatory microRNA is spreading, Cancer Res., 69, 7495, 10.1158/0008-5472.CAN-09-2111 Pencheva, 2013, Control of metastatic progression by microRNA regulatory networks, Nat. Cell Biol., 15, 546, 10.1038/ncb2769 Ma, 2007, Tumour invasion and metastasis initiated by microRNA-10b in breast cancer, Nature, 449, 682, 10.1038/nature06174 Ma, 2010, Role of miR-10b in breast cancer metastasis, Breast Cancer Res., 12, 210, 10.1186/bcr2720 Krutzfeldt, 2005, Silencing of microRNAs in vivo with ‘antagomirs’, Nature, 438, 685, 10.1038/nature04303 Lennox, 2013, Improved performance of anti-miRNA oligonucleotides using a novel non-nucleotide modifier, Mol. Ther. Nucleic Acids, 2, e117, 10.1038/mtna.2013.46 Ma, 2010, Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model, Nat. Biotechnol., 28, 341, 10.1038/nbt.1618 Allen, 2013, Liposomal drug delivery systems: From concept to clinical applications, Adv. Drug Deliv. Rev., 65, 36, 10.1016/j.addr.2012.09.037 Yang, 2014, Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas, Biomaterials, 35, 5226, 10.1016/j.biomaterials.2014.03.017 Yan, 2013, Particle carriers for combating multidrug-resistant cancer, ACS Nano, 7, 9512, 10.1021/nn405632s Nakamura, 2011, A double-modulation strategy in cancer treatment with a chemotherapeutic agent and siRNA, Mol. Ther., 19, 2040, 10.1038/mt.2011.174 Yin, 2008, Physicochemical characteristics of pH-sensitive poly(L-histidine)-b-poly(ethylene glycol)/poly(L-lactide)-b-poly(-ethylene glycol) mixed micelles, J. Control. Release, 126, 130, 10.1016/j.jconrel.2007.11.014 Wu, 2013, pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery, Biomaterials, 34, 1213, 10.1016/j.biomaterials.2012.08.072 Sato, 2012, A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo, J. Control. Release, 163, 267, 10.1016/j.jconrel.2012.09.009 Toriyabe, 2013, The transfection activity of R8-modified nanoparticles and siRNA condensation using pH sensitive stearylated-octahistidine, Biomaterials, 34, 1337, 10.1016/j.biomaterials.2012.10.043 Tian, 2012, Cancer nanomedicines targeting tumor extracellular pH, Colloids Surf. B: Biointerfaces, 99, 116, 10.1016/j.colsurfb.2011.10.039 Jiang, 2012, Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery, Biomaterials, 33, 9246, 10.1016/j.biomaterials.2012.09.027 Zhao, 2012, The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel, Biomaterials, 33, 2508, 10.1016/j.biomaterials.2011.11.078 Zhang, 2011, Design of acid-activated cell penetrating peptide for delivery of active molecules into cancer cells, Bioconjug. Chem., 22, 1410, 10.1021/bc200138d Zhang, 2013, A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system, Biomaterials, 34, 7980, 10.1016/j.biomaterials.2013.07.014 Tu, 2009, Constructing bioactive peptides with pH-dependent activities, Peptides, 30, 1523, 10.1016/j.peptides.2009.05.009 Li, 2010, Design and characterization of an acid-activated antimicrobial peptide, Chem. Biol. Drug Des., 75, 127, 10.1111/j.1747-0285.2009.00904.x Makovitzki, 2009, Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense–like lytic peptides, Cancer Res., 69, 3458, 10.1158/0008-5472.CAN-08-3021 Splith, 2011, Antimicrobial peptides with cell-penetrating peptide properties and vice versa, Eur. Biophys. J., 40, 387, 10.1007/s00249-011-0682-7 Zhang, 2014, Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model, J. Control. Release, 182, 90, 10.1016/j.jconrel.2014.03.016 Ye, 2012, Synergistic effects of cell-penetrating peptide Tat and fusogenic peptide HA2-enhanced cellular internalization and gene transduction of organosilica nanoparticles, Nanomedicine, 8, 833, 10.1016/j.nano.2011.10.003 Mo, 2012, Multistage pH-responsive liposomes for mitochondrial targeting anticancer drug delivery, Adv. Mater., 24, 3659, 10.1002/adma.201201498 Papo, 2004, Suppression of human prostate tumor growth in mice by a cytolytic D-, L-amino acid peptide: membrane lysis, increased necrosis, and inhibition of prostate- specific antigen secretion, Cancer Res., 64, 5779, 10.1158/0008-5472.CAN-04-1438 Papo, 2006, Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide, Cancer Res., 66, 5371, 10.1158/0008-5472.CAN-05-4569 Gradishar, 2012, Phase II trial of nab-paclitaxel compared with docetaxel as first-line chemotherapy in patients with metastatic breast cancer: final analysis of overall survival, Clin. Breast Cancer, 12, 313, 10.1016/j.clbc.2012.05.001 Ganguly, 2011, Class III β-tubulin counteracts the ability of paclitaxel to inhibit cell migration, Oncotarget, 2, 368, 10.18632/oncotarget.250 Chiu, 2004, Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells, Chem. Biol., 11, 1165, 10.1016/j.chembiol.2004.06.006 Gilleron, 2013, Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape, Nat. Biotechnol., 31, 638, 10.1038/nbt.2612 Xiang, 2012, Uptake mechanisms of non-viral gene delivery, J. Control. Release, 158, 371, 10.1016/j.jconrel.2011.09.093 Xu, 2013, Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances, Adv. Drug Deliv. Rev., 65, 121, 10.1016/j.addr.2012.09.041 Li, 2012, An arginine derivative contained nanostructure lipid carriers with pH-sensitive membranolytic capability for lysosomolytic anti-cancer drug delivery, Int. J. Pharm., 436, 248, 10.1016/j.ijpharm.2012.06.040 Ma, 2010, miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis, Nat. Cell Biol., 12, 247, 10.1038/ncb2024 Schuldt, 2007, Micromanaging metastasis, Nat. Cell Biol., 9, 1121, 10.1038/ncb1007-1121 Negrini, 2008, Breast cancer metastasis: a microRNA story, Breast Cancer Res., 10, 203, 10.1186/bcr1867 Zhang, 2013, Stearylated antimicrobial peptide [D]-K6L9 with cell penetrating property for efficient gene transfer, Peptides, 46, 33, 10.1016/j.peptides.2013.05.011 Varkouhi, 2011, Endosomal escape pathways for delivery of biological, J. Control. Release, 151, 220, 10.1016/j.jconrel.2010.11.004 Ruggiero, 2010, Paradoxical glomerular filtration of carbon nanotubes, Proc. Natl. Acad. Sci. U. S. A., 107, 12369, 10.1073/pnas.0913667107 Bertrand, 2014, Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology, Adv. Drug Deliv. Rev., 66, 2, 10.1016/j.addr.2013.11.009 Neri, 2011, Interfering with pH regulation in tumours as a therapeutic strategy, Nat. Rev. Drug Discov., 10, 767, 10.1038/nrd3554 Hatakeyama, 2014, The systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice, J. Control. Release, 173, 43, 10.1016/j.jconrel.2013.10.023 Zhang, 2013, Lactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma, J. Control. Release, 168, 251, 10.1016/j.jconrel.2013.03.020 Takahashi, 2013, In vitro optimization of 20-OMe-40-thioribonucleoside–modified anti-microRNA oligonucleotides and its targeting delivery to mouse liver using a liposomal nanoparticle, Nucleic Acids Res., 41, 10659, 10.1093/nar/gkt823 Liu, 2011, Targeted delivery of antisense inhibitor of miRNA for antiangiogenesis therapy using cRGD-functionalized nanoparticles, Mol. Pharm., 8, 250, 10.1021/mp100315q Urban, 2012, Nanotools for the delivery of antimicrobial peptides, Curr. Drug Targets, 13, 1158, 10.2174/138945012802002302 Huang, 2013, Hybrid melittin cytolytic peptide-driven ultrasmall lipid nanoparticles block melanoma growth in vivo, ACS Nano, 7, 5791, 10.1021/nn400683s Lopez-Abarrategui, 2013, Magnetic nanoparticles: new players in antimicrobial peptide therapeutics, Curr. Protein Pept. Sci., 14, 595, 10.2174/1389203711209070682 Hou, 2013, Melittin derived peptides for nanoparticle based siRNA transfection, Biomaterials, 34, 3110, 10.1016/j.biomaterials.2013.01.037 Sun, 2011, Simultaneous delivery of siRNA and paclitaxel via a “two-in-one” micelleplex promotes synergistic tumor suppression, ACS Nano, 5, 1483, 10.1021/nn103349h Eldar-Boock, 2013, Nano-sized polymers and liposomes designed to deliver combination therapy for cancer, Curr. Opin. Biotechnol., 24, 682, 10.1016/j.copbio.2013.04.014 Taratula, 2013, Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA, J. Control. Release, 171, 349, 10.1016/j.jconrel.2013.04.018